Prognostic factors for acute and late skin reactions in radiotheraphy patients

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 5, 1996, Pages 1065-1075

  Turesson, Ingela ^a   Nyman, Jan ^a   Holmberg, Erik ^a   Oden, Anders ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute skin reactions; Late skin reactions; Prognostic factors; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; ERYTHEMA; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIOSENSITIVITY; REFLECTOMETRY; SINGLE BLIND PROCEDURE; SKIN MANIFESTATION; TELANGIECTASIA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIOTHERAPY; SKIN;

EID: 0030474646     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00426-9     Document Type: Article

References (34)

1. 1. Arlett, C. F.; Harcourt, S. A. Survey of radiosensitivity in a variety of human cell strains. Cancer Res. 40:926-932; 1980.
2. 2. Bentzen, S. M.; Overgaard, J. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin. Radiat. Oncol. 4(2):68-80; 1994.
3. 3. Bentzen, S. M.; Overgaard, M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother. Oncol. 20:159-165; 1991.
4. 4. Bentzen, S. M.; Overgaard, M.; Thames, H. D. Fractionation sensitivity of a functional endpoint: Impaired shoulder movement after postmastectomy radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 17:531-537; 1989.
5. 5. Bentzen, S. M.; Thames, H. D.; Overgaard, M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother. Oncol. 15:267-274; 1989.
6. 6. Cox, D. R.; Oakes, D. Analysis of survival data. London: Chapman and Hall; 1984.
7. 7. Deschavanne, P. J.; Debieu, D.; Fertil, B.; et al. Reevaluation of in vitro radiosensitivity of human fibroblasts of different genetic origins. Int. J. Radiat. Biol. 50(2):297-293; 1986.
8. 8. Fleck, R.; McNeese, M. D.; Ellerbroek, N. A.; et al. Consequences of breast irradiation in patients with preexisting collagen vascular disease. Int. J. Radiat. Oncol. Biol. Phys. 17:829-833; 1989.
9. 9. Gehrig, J.; Hacki, W. H.; Schulthess, H. K.; et al. Strahlenproktokolitis nach gynäkologischer Radiotherapie: Eine endoskopische Studie. Schweiz Med. Wochenschr. 117:1326-332; 1987.
10. 10. Jensen, B. V.; Carlsen, N. L.; Nissen, N. I. Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease. Eur. Respir. J. 3:1140-1145; 1990.
11. 11. Koga, K.; Kusumoto, S.; Watanabe, K.; et al. Age factor relevant to the development of radiation pneumonitis in radiotherapy of lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 14:367-371; 1988.
12. 12. Kucera, H.; Enzelsberger, H.; Eppel, W.; et al. The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer 60:1-4; 1987.
13. 13. Lawton, C. A.; Won, M.; Pilepich, M. V.; et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706. Int. J. Radiat. Oncol. Biol. Phys. 21:935-939; 1991.
14. 14. Livengood, C. H.; Soper, J. T.; Clarke-Pearson, D. L.; et al. Necrotizing fasciitis in irradiated tissue from diabetic women. A report of two cases. J. Reprod. Med. 36:455-458; 1991.
15. 15. Olsen, N. K.; Pfeiffer, P.; Johannsen, L.; et al. Radiation-induced brachial plexopathy: Neurological follow-up in 161 recurrencefree breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 26:43-49; 1993.
16. 16. Peters, L. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response. Radiother. Oncol. 17:177-190; 1990.
17. 17. Rathmell, A. J.; Taylor, R. E. Enhanced normal tissue response to radiation in a patient with discoid lupus erythematosus. Clin. Oncol. 4:331-332; 1992.
18. 18. Robertson, J. M.; Clarke, D. H.; Pevzner, M. M.; et al. Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer 68:502-508; 1991.
19. 19. Ross, J. G.; Hussey, D. H.; Mayr, N. A.; et al. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer 71:3744-3752; 1993.
20. 20. Rugg, T.; Saunders, M. I.; Dische, S. Smoking and mucosal reactions to radiotherapy. Br. J. Radiol. 63:554-556; 1990.
21. 21. Smith, L. M.; Mendenhall, N. P.; Cicale, M. J.; et al. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. Int. J. Radiat. Oncol. Biol. Phys. 16:79-84; 1989.
22. 22. Stewart, F. A.; Lebesque, J. V.; Hart, A. A. M. Progressive development of radiation damage in mouse kidneys and consequences for reirradiation tolerance. Int. J. Radiat. Biol. 53:405-415; 1988.
23. 23. Stewart, F. A.; Michael, B. D.; Denekamp, J. Late radiation damage in the mouse bladder as measured by increased urinary frequency. Radiat. Res. 75:649-659; 1978.
24. 24. Swift, M.; Reitnauer, P. J.; Morell, D.; et al. Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med. 316:1289-1294; 1987.
25. 25. Terhaard, C. H.; Snippe, K.; Ravasz, L. A.; et al. Radiotherapy in T1 laryngeal cancer: Prognostic factors for locoregional control and survival, uni-and multivariate analysis. Int. J. Radiat. Oncol. Biol. Phys. 21:1179-1186; 1991.
26. 26. Thames, H. D.; Hendry, J. H.; Moore, J. V.; Ang, K. K.; Travis, E. L. The high steepness of dose-response curves for late responding normal tissues. Radiother. Oncol. 15:49-53; 1989.
27. 27. Tucker, S. L.; Turesson, I.; Thames, H. D. Evidence for individual differences in the radiosensitivity of human skin. Eur. J. Cancer 28A:1783-1791; 1992.
28. 28. Turesson, I. Characteristics of dose-response relationships for late radiation effects: An analysis of skin telangiectasia and of head and neck morbidity. Radiother. Oncol. 20:149-158; 1991.
29. 29. Turesson, I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int. J. Radiat. Oncol. Biol. Phys. 19:1569-1574; 1990.
30. 30. Turesson, I. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships. Radiother. Oncol. 15:217-226; 1989.
31. 31. Turesson, I.; Notter, G. Accelerated vs. conventional fractionation. The degree of incomplete repair in human skin with a four-hour-fraction interval studied after postmastectomy irradiation. Acta Oncol 27:169-179; 1988.
32. 32. Turesson, I.; Notter, G. The predictive value of skin telangiectasia for late radiation effects in different normal tissues. Int. J. Radiat. Oncol. Biol. Phys. 12:603-609; 1986.
33. 33. Turesson, I.; Thames, H. D. Repair capacity and kinetics of human skin during fractionated radiotherapy: Erythema, desquamation and telangictasia after 3 and 5 years follow-up. Radiother. Oncol. 15:169-188; 1989.
34. 34. Van der Kogel, A. J. Late effects of radiation on the spinal cord. Dose-effect relationships and pathogenesis. Thesis, University of Amsterdam; 1979.